VAXXINOVA NORWAY AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−35,5 mill kr).
- Nylig endring 2026-07-21 Aksjekapital registrert 2026-07-21.
VAXXINOVA NORWAY AS is registered as a limited company in Bergen, Vestland with organisation number 995153637. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2010 and has 23 registered employees. Registered share capital is NOK 100,000, divided into 100 shares. The company's stated purpose is: “Forskning og utvikling, salg, markedsføring og teknisk støtte relatert til veterinærmedisinske produkter og tjenester, spesielt biologiske produkter for akvakulturindustrien, samt deltagelse i annen forretningsvirksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 17.7m in revenue and NOK −35.5m in operating profit.
Key figures · 2025
Financial health · 2025
Who owns VAXXINOVA NORWAY AS?
VAXXINOVA NORWAY AS has 1 registered shareholder:
- VAXXINOVA INTERNATIONAL B.V. 100.0%
Frequently asked questions about VAXXINOVA NORWAY AS
Who owns VAXXINOVA NORWAY AS?
VAXXINOVA INTERNATIONAL B.V. is the largest registered owner, with 100.0%.
What is the revenue of VAXXINOVA NORWAY AS?
VAXXINOVA NORWAY AS had revenue of NOK 17.7m in 2025.
Who is the general manager of VAXXINOVA NORWAY AS?
Luis Matias Del Campo Barquin is registered as general manager of VAXXINOVA NORWAY AS.
Where is VAXXINOVA NORWAY AS based?
VAXXINOVA NORWAY AS has its business address in Bergen.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.